NEW YORK, Nov. 26, 2014 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Albany Molecular Research, Inc. ("Albany" or the "Company") (NASDAQ: AMRI) of the January 12, 2015 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Albany and certain officers of the Company.
A complaint has been filed in the United States District Court for the Eastern District of New York on behalf of all persons who purchased Albany common stock between August 5, 2014 and November 5, 2014 (the "Class Period").
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, Albany issued false and misleading statements concerning operations at its OsoBio facility.
On November 5, 2014, the Company announced that a business interruption event at its OsoBio facility in late July resulted in weak third quarter 2014 results and that the facility would not be back online until mid-November.
Following this news, the price of Albany's stock declined by $6.08 per share, or over 26%, to close on November 5, 2014 at $16.59 per share.
Request more information now by clicking here: www.faruqilaw.com/AMRI. There is no cost or obligation to you.
If you invested in Albany common stock, bonds or options between August 5, 2014 and November 5, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/AMRI. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Albany's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-albany-molecular-research-inc-amri-to-contact-the-firm-300001782.html
SOURCE Faruqi & Faruqi, LLP